Inactive Instrument

News MiMedx Group Inc Nasdaq

Equities

US6024961012

Real-time Estimate Cboe BZX Other stock markets 01:27:36 2024-04-24 pm EDT			5-day change	1st Jan Change
6.435 ^USD	+129.82%		-52.57%	-76.61%

Mar. 27	MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products	MT
Mar. 27	MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30	Apr. 16	AQ
MIMEDX Provides Update on AXIOFILL Request for Designation from FDA	Mar. 28	AQ
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024	Mar. 27	AQ
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products	Mar. 27	MT
MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit	Mar. 27	DJ
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA	Mar. 27	AQ
MiMedx Group, Inc. Provides Update on AXIOFILL Request for Designation from FDA	Mar. 27	CI
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	Mar. 20	MT
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	Mar. 20	AQ
MiMedx Launches E-Commerce Platform	Mar. 13	MT
MIMEDX Introduces E-Commerce and Account Management Platform	Mar. 13	AQ
Mimedx Introduces E-Commerce and Account Management Platform	Mar. 13	CI
Lake Street Starts MiMedx Group With Buy Rating, $12 Price Target	Mar. 07	MT
MIMEDX Announces Appointment of Two New Independent Directors	Mar. 04	AQ
MiMedx Group, Inc. Announces Appointment of New Independent Directors	Mar. 04	CI
Mizuho Securities Raises Price Target on MiMedx to $14 From $13, Maintains Buy Rating	Mar. 01	MT
Spectral AI Names Peter Carlson Chief Executive Officer; Reaffirms 2024 Preliminary Revenue Guidance	Mar. 01	MT
MiMedx: Q4 Earnings Snapshot	Feb. 28	AQ
Transcript : MiMedx Group, Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Earnings Flash (MDXG) MIMEDX GROUP Posts Q4 Revenue $86.8M, vs. Street Est of $85.2M	Feb. 28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News MiMedx Group Inc Nasdaq

Equities

US6024961012

Summary

Filters